A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension

A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension

Aims: The aim was to compare efficacy and cost-effectiveness of bimatoprost 0.03% and brimonidine 0.2% in primary open-angle glaucoma (POAG)/ocular hypertension (OHT). Settings and Design: Open, randomized, cross-over, comparative study. Materials and Methods: Forty patients of POAG or OHT with intr...

Full description

Bibliographic Details
Main Authors: Navreet Kaur Natt, A Gupta, G Singh, T Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Malignant glaucoma
pseudophakic
surgical management
zonulo-hyaloido-vitrectomy
Automated retinal imaging
diabetic retinopathy
screening
Low vision
low vision aids
quality of life
Children
congenital cataract
hydrophobic acrylic intraocular lens
intraocular lens implantation
myopic shift
polymethyl methacrylate
Cost-effectiveness
glaucoma
pharmacoeconomics
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2014;volume=62;issue=12;spage=1136;epage=1140;aulast=Natt

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2014;volume=62;issue=12;spage=1136;epage=1140;aulast=Natt

Similar Items